Who organised and funded the psoriasis PSP? 

This PSP was funded by the Psoriasis Association and led by Dr Helen Young from the University of Manchester, in collaboration with the James Lind Alliance and the University of Nottingham.

Key decisions about the PSP process were made by a Steering Committee made up of various different representatives, including patients. The Steering Committee was independently chaired by a James Lind Alliance Advisor.

PSP Partners

We are delighted that the following organisations supported and promoted the psoriasis PSP to their networks:

  • The British Association of Dermatologists (BAD)
  • The British Dermatological Nursing Group (BDNG)
  • The Primary Care Dermatology Society (PCDS)
  • The International Psoriasis Council (IPC)
  • The UK Dermatology Clinical Trials Network (UKDCTN)

James Lind Alliance

The James Lind Alliance (JLA) is a non-profit-making initiative, established in 2004. It brings patients, carers and clinicians together in Priority Setting Partnerships (PSPs), the aim of which is to identify and prioritise uncertainties, or ‘unanswered questions’, about the effectsof treatments and interventions in different health conditions, topics or settings.

The JLA believes that addressing uncertainties about the effects of treatments or interventions should become accepted as a much more routine part of clinical practice, and patients, carers and clinicians should work together to agree which, among those uncertainties, matter most and thus deserve priority attention.

The JLA is funded by the National Institute for Health Research (NIHR) and is coordinated through the NIHR Evaluation, Trials and Studies Coordinating Centre (NETSCC). To find out more about current and past PSPs, please visit www.jla.nihr.ac.uk.